A detailed history of Connors Investor Services Inc transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Connors Investor Services Inc holds 7,545 shares of SLP stock, worth $226,651. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,545
Previous 6,645 13.54%
Holding current value
$226,651
Previous $323,000 25.39%
% of portfolio
0.02%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.46 - $46.86 $27,414 - $42,174
900 Added 13.54%
7,545 $241,000
Q4 2023

Feb 14, 2024

BUY
$33.36 - $45.71 $26,688 - $36,568
800 Added 13.69%
6,645 $297,000
Q2 2023

Aug 14, 2023

SELL
$40.45 - $48.0 $40,450 - $48,000
-1,000 Reduced 14.61%
5,845 $253,000
Q1 2023

May 15, 2023

BUY
$34.96 - $43.94 $17,480 - $21,970
500 Added 7.88%
6,845 $300,000
Q4 2022

Feb 15, 2023

BUY
$36.55 - $51.15 $231,909 - $324,546
6,345 New
6,345 $232,000
Q3 2020

Nov 16, 2020

SELL
$57.51 - $75.36 $292,840 - $383,733
-5,092 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$32.91 - $59.82 $109,952 - $199,858
-3,341 Reduced 39.62%
5,092 $305,000
Q1 2020

May 14, 2020

SELL
$26.79 - $38.99 $29,522 - $42,966
-1,102 Reduced 11.56%
8,433 $294,000
Q3 2019

Oct 28, 2019

SELL
$28.19 - $41.75 $126,375 - $187,165
-4,483 Reduced 31.98%
9,535 $331,000
Q2 2019

Aug 14, 2019

SELL
$19.91 - $28.97 $117,966 - $171,647
-5,925 Reduced 29.71%
14,018 $400,000
Q1 2019

May 10, 2019

SELL
$18.84 - $21.36 $34,175 - $38,747
-1,814 Reduced 8.34%
19,943 $421,000
Q2 2018

Aug 13, 2018

SELL
$14.65 - $23.75 $90,830 - $147,250
-6,200 Reduced 22.18%
21,757 $484,000
Q4 2017

Feb 13, 2018

SELL
$15.3 - $17.4 $61,200 - $69,600
-4,000 Reduced 12.52%
27,957 $450,000
Q3 2017

Nov 13, 2017

BUY
$13.7 - $15.65 $437,810 - $500,127
31,957
31,957 $495,000

Others Institutions Holding SLP

About Simulations Plus, Inc.


  • Ticker SLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 20,297,700
  • Market Cap $610M
  • Description
  • Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...
More about SLP
Track This Portfolio

Track Connors Investor Services Inc Portfolio

Follow Connors Investor Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Connors Investor Services Inc with notifications on news.